Antifungal susceptibilities of dermatophytic agents isolated from clinical specimens

European Journal of Dermatology

Volumn 15, Issue 4, 2005, Pages 258-261

  Cetinkaya, Zafer ^a   Kiraz, Nuri ^b   Karaca, Semsettin ^a   Kulac, Mustafa ^a   Ciftci, Ihsan H ^a   Aktepe, Orhan C ^a   Altindis, Mustafa ^a   Kiyildi, Nilay ^a   Piyade, Meltem ^a  

^a AFYON KOCATEPE UNIVERSITY   (Turkey)

^b ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

Antifungal susceptibility; Dermatophytes

Indexed keywords

FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; TERBINAFINE;

ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DERMATOPHYTE; FOOT; HAND; HEAD; HUMAN; IN VITRO STUDY; INGUINAL REGION; MINIMUM INHIBITORY CONCENTRATION; NAIL; TOE; TRICHOPHYTON RUBRUM; TRICHOPHYTON TONSURANS; TRUNK;

ADMINISTRATION, CUTANEOUS; ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DERMATOMYCOSES; FLUCONAZOLE; HUMANS; ITRACONAZOLE; KETOCONAZOLE; MICROBIAL SENSITIVITY TESTS; NAPHTHALENES;

EID: 22544437853     PISSN: 11671122     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Niewerth M, Korting HC. The use of systemic antimycotics in dermatotherapy. Eur J Dermatol 2000; 10(2): 155-60.
2. Odds F, Ausma J, Van Gevren F, Woestenborghs F, Meerpoel L, Heeres J, et al. In vitro and in vivo activities or the novel azole antifungal agent R126638. Antimicrob Agents Chemother 2004; 48: 388-91.
3. Fernandez-Torres B, Cabanes FJ, Carrillo-Munoz AJ, Esteban A, Inza I, Abarca L, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999-4003.
4. Korting HC, Ollert M, Abeck D, and the German Collaborative Dermatophyte Drug Susceptibility Study Group. Results of German multicenter study of antimicrobial susceptibilities of Trichophyton rubrum and Trichophyton mentagrophytes strains causing tinea unguium. Antimicrob Agents Chemother 1995; 39: 1206-8.
5. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA. Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000: 341-4.
6. Summerbell RC. Trichophyton, Microsporum, Epidermophyton and agents of superficial mycoses. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH, eds. Manuel of clinical microbiology. Washington 8th Ed. 2003: 1798-819.
7. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved standard M38-A. Pennsylvania USA: Wayne, 2002; [NCCLS document M38-A (ISBN 1-56238-470-8)].
8. Perea S, Fothergill AW, Sutton DA, Michael G, Rinaldi MG. Comparison of in vitro activities of voriconazole and five established antifungal agents against different species of dermatophytes using a broth macrodilution method. J Clin Microbiol 2001; 39: 385-8.
9. Tosti A, Piraccini BM, Mariani R, Stinchi C, Buttasi C. Are local and systemic conditions important for the development of onychomycosis? Eur J Dermatol 1998; 8(1): 41-4.
10. Bonifaz A, Saul A. Treatment of tinea pedis with a single pulse of itraconazole. Eur J Dermatol 2002; 12(2): 157-9.
11. Favre B, Hofbauer B, Hildering KS, Ryder NS. Comparison of in vitro activities of 17 antifungal drugs against a panel of 20 dermatophytes by using a microdilution assay. J Clin Microbiol 2003; 41: 4817-9.
12. Seishima M, Oyama Z, Oda M, Ishigo S. Distribution of an antifungal drug, itraconazole, in pathological and non-pathological tissues. Eur J Dermatol 2004; 14(1): 24-7.
13. Johnson LB, Kauffman CA. Voriconazole: a new triazole antifungal agent. Clin Infect Dis 2003; 36: 630-7.
14. Gordon E, Schutze MD. Antifungal agents for the treatment of systemic mycoses. Semin Pediatr Infect Dis 2001; 12(3): 794-8.
15. Nimura K, Niwano Y, Ishiduka S, Fukumoto R. Comparison of in vitro antifungal activities of topical antimycotics launched in 1990s in Japan, int J Antimicrob Agents 2001; 18: 173-8.
16. Fernandez-Torres B, Carrillo AJ, Martin E, Palacio AD, Moore MK, Valverde A, et al. In Vitro Activities of 10 antifungal drugs against 508 dermatophytes strains. Antimicrob Agents Chemother 2001; 45(9): 2524-8.
17. Duver I, Bozkurt M, Kalkanci A, Gunes I, Kustimur S. In: Dermatophytes isolated from clinical specimens and antifungal susceptibilities. Ankara: National Fungal Diseases and Clinical Mycology Congress, 2001: 258-9; [2.].
18. Gupta AK, Kohli Y. In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. Br J Dermatol 2003; 149(2): 296-305.